Drugs Made In America Acquisition Corp. (DMAAU) Return on Capital Employed (2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Return on Capital Employed came in at 1.18% in Q4 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Return on Capital Employed (2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 1 years of Return on Capital Employed data on file, last reported at 1.18% in Q4 2025.
- Quarterly Return on Capital Employed changed N/A year-over-year to 1.18% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.18% (changed N/A YoY) and the FY2025 annual result came in at 2.35%, changed N/A from the prior year.
- Return on Capital Employed held at 1.18% in Q4 2025.
- In the past five years, Return on Capital Employed ranged from a high of 1.18% in Q4 2025 to a low of 1.18% in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.18% |